Macquarie Group LTD Invitae Corp Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $3,492 - $15,861	-1,838 Reduced 51.18%	1,753 $9,000
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $32.3 Million - $80.2 Million	-5,145,640 Reduced 99.93%	3,591 $29,000
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $29 Million - $56.6 Million	-1,975,434 Reduced 27.73%	5,149,231 $78.6 Million
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $26.4 Million - $36.5 Million	1,086,200 Added 17.99%	7,124,665 $203 Million
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $52.2 Million - $80.9 Million	2,001,513 Added 49.58%	6,038,465 $204 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $22 Million - $37.8 Million	664,087 Added 19.69%	4,036,952 $154 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $8.39 Million - $12.3 Million	-214,688 Reduced 5.98%	3,372,865 $141 Million
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $10.9 Million - $17.1 Million	-383,716 Reduced 9.66%	3,587,553 $156 Million
Q2 2020 Aug 11, 2020	BUY	$11.71 - $30.29 $24.9 Million - $64.3 Million	2,122,842 Added 114.85%	3,971,269 $120 Million
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $2.41 Million - $8.69 Million	-315,898 Reduced 14.6%	1,848,427 $25.3 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $7.15 Million - $9.79 Million	-475,991 Reduced 18.03%	2,164,325 $34.9 Million
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $36.9 Million - $53.8 Million	1,955,719 Added 285.67%	2,640,316 $50.9 Million
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $10.7 Million - $16.1 Million	613,312 Added 860.37%	684,597 $16.1 Million
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $759,185 - $1.84 Million	71,285 New	71,285 $1.67 Million
Q1 2018 May 11, 2018	SELL	$4.69 - $10.05 $4,221 - $9,045	-900 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$7.86 - $9.99 $7,074 - $8,991	900	900 $8,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account